Rashtbari Samaneh, Hassanpour Aydinlou Zahra, Sadeghi Leila
Department of Animal Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran.
Bioimpacts. 2024;14(5):29946. doi: 10.34172/bi.2024.29946. Epub 2024 Feb 5.
FeO NPs can enter cells quickly, pass through the blood-brain barrier and interact with macromolecules. These materials are widely used in different fields, so their risk assessment is among the most critical issues. Acetylcholinesterase (AChE) is a cholinergic enzyme in central and peripheral nervous systems.
In this work, the possible effects of FeO NPs on the structure and catalytic activity of AChE were investigated using circular dichroism (CD), surface plasmon resonance (SPR), and fluorescence spectroscopies.
The outcomes demonstrated that 5 nm FeO NPs inhibit AChE activity through mixed mechanism. While 50 nm FeO NPs caused an enhancement in the catalytic activity up to 60 nM. However, higher concentrations of FeO NPs (above 60 nM) hindered the enzyme activity via mixed mechanism. Fluorescence analysis showed that NPs can quench the fluorescence intensity of AChE that refer to conformational changes. Furthermore, CD results showed that FeO NPs can reduce the α-helix and β-sheet contents of the enzyme and decrease the stability of AChE. Also, the SPR data analysis showed that the affinity between AChE and FeO NPs decreased with rising temperature. After treatment with FeO NPs, the catalytic activity of AChE was assessed in HepG2 cell lines, and the results confirmed the inhibitory effects of FeO NPs on AChE activity .
These findings provide helpful information about the impact of FeO NPs on the structure and function of AChE and could offer new insights into the risk assessment of the medical application of nanoparticles.
FeO纳米颗粒可快速进入细胞,穿过血脑屏障并与大分子相互作用。这些材料在不同领域广泛应用,因此其风险评估是最关键的问题之一。乙酰胆碱酯酶(AChE)是中枢和外周神经系统中的一种胆碱能酶。
在本研究中,使用圆二色性(CD)、表面等离子体共振(SPR)和荧光光谱法研究了FeO纳米颗粒对AChE结构和催化活性的可能影响。
结果表明,5nm的FeO纳米颗粒通过混合机制抑制AChE活性。而50nm的FeO纳米颗粒可使催化活性增强至60nM。然而,更高浓度的FeO纳米颗粒(高于60nM)通过混合机制阻碍酶活性。荧光分析表明,纳米颗粒可淬灭AChE的荧光强度,这表明构象发生了变化。此外,CD结果表明,FeO纳米颗粒可降低该酶的α-螺旋和β-折叠含量,并降低AChE的稳定性。SPR数据分析还表明,AChE与FeO纳米颗粒之间的亲和力随温度升高而降低。在用FeO纳米颗粒处理后,在HepG2细胞系中评估了AChE的催化活性,结果证实了FeO纳米颗粒对AChE活性的抑制作用。
这些发现为FeO纳米颗粒对AChE结构和功能的影响提供了有用信息,并可为纳米颗粒医学应用的风险评估提供新的见解。